Advances in adjuvant therapy for breast cancer

Clinical Advances in Hematology and Oncology

Volumn 4, Issue 3 SUPPL. 7, 2006, Pages 1-

  Slamon, Dennis J ^a   Romond, Edward H ^b   Perez, Edith A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROURACIL; HORMONE RECEPTOR; METHOTREXATE; TRASTUZUMAB; ANGIOGENESIS INHIBITOR; ANTHRACYCLINE; ANTINEOPLASTIC AGENT;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG EFFICACY; DRUG TARGETING; EDITORIAL; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RISK REDUCTION; ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST TUMOR; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; FEMALE; METHODOLOGY; MORTALITY; SURVIVAL RATE;

ANGIOGENESIS INHIBITORS; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; RECEPTOR, ERBB-2; SURVIVAL RATE;

EID: 35848933669     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (0)